Resource Filtering Tool
Article
Overcoming the Complex Challenges in Schizophrenia Trials
Schizophrenia is a disabling, lifelong disease that is difficult to diagnose and treat due to its complexities and challenges. These same intricacies and complications are a critical part of clinical trial development that require a deep understanding of the disease and how to mitigate the anticipated challenges during trial design necessary to advance treatment without delaying study timelines. we discuss how to overcome three of the most complex challenges of any Schizophrenia trial:
Assessments and Scales. Raters and Site Management, and Recruitment and Retention.
Blog Post
How Do You Determine the Best Clinical Pharmacology Strategy for Your Product?
Clinical pharmacology is an important cornerstone of the clinical development of drugs, which this blog post has only begun to introduce. Future blog posts will focus on various aspects of clinical pharmacology, including the types of studies that comprise a clinical pharmacology program, a comparison of clinical pharmacology programs for large and small molecules, evaluations of drug interactions, and regulatory considerations for clinical pharmacology.
